BIOLYN
CJC-1295 with DAC pharmaceutical vial
In Stock
CAS: 863288-34-0

CJC-1295 with DAC

Long-Acting GHRH Analog with Drug Affinity Complex

CJC-1295 with DAC is a modified GHRH analog conjugated to a Drug Affinity Complex for extended half-life. Biolyn supplies research-grade CJC-1295 DAC for endocrine research and B2B partners.

Technical Profile

Modified GRF(1-29) with amino acid substitutions (Ala2, Gln8, Ala15, Leu27) conjugated to a reactive Drug Affinity Complex (DAC) that binds serum albumin in vivo, extending half-life to ~8 days.

CAS Number863288-34-0
Molecular Weight3,647.28 g/mol
Molecular FormulaC165H269N47O46
Purity>99% (HPLC)
FormLyophilized Powder
Storage-20C, desiccated, protected from light
Applications
Extended GH release researchGHRH receptor studiesEndocrine pharmacokineticsLong-acting peptide developmentB2B API supply
BIOLYN

European-based supplier of high-purity peptide APIs for pharmaceutical development, research institutions, and cosmetic manufacturers.

Contact

info@biolynpharma.com

Amsterdam, The Netherlands

2026 Biolyn Pharmaceutical B.V. All rights reserved.